glutathione and liver disease A Literature Review of Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Glutathione supplement for fatty liver

Ann Oncol 18(8):14001407 Reardon DA et al (2007) Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

It also activates focal adhesion kinase (FAK) and paxillin signalling, facilitating cell migration to wound sites

[DOI] [PubMed] [Google Scholar] 23.Perez-Montero B., Fermin-Rodriguez M.L., Portero-Fuentes M., Sarquis J., Caceres S., Del Portal J.C.I., de Juan L., Miro G., Cruz-Lopez F

D.JongbloedW.HeijstJ

The breadth of gene modulation raises a fundamental question: how does a three-amino-acid peptide influence thousands of genes